Personalized Treatment of Refractory BPPV
Personalized Medicine to Treat Refractory Benign Paroxysmal Positional Vertigo, Through Computational Fluid Dynamics Analysis From Magnetic Resonance Image Reconstructions
1 other identifier
interventional
54
1 country
1
Brief Summary
Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden. Variations in the anatomical orientation of the semicircular canals (SCCs) may explain the resistance to conventional maneuvers. This study explores a personalized medicine approach, utilizing computational fluid dynamics (CFD) based on MRI reconstructions to tailor CRMs with the help of mechanical rotation chair according to individual inner ear anatomy. Methods: The investigators conducted a randomized, multicenter, open-label study targeting patients with refractory posterior canal BPPV. Participants were allocated to either a control group (receiving repeated standard CRMs and Brandt-Daroff exercises) or an intervention group (receiving personalized CRMs based on CFD simulations derived from MRI scans). The intervention group's maneuvers were executed using a mechanical rotational chair designed for precise angulation. Primary outcomes included resolution of nystagmus and vertigo symptoms, while secondary outcomes measured the reduction in healthcare visits and improved quality of life (Dizziness Handicap Inventory score).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 2, 2024
CompletedFirst Posted
Study publicly available on registry
December 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 10, 2024
December 1, 2024
2 years
December 2, 2024
December 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of curation
Percentage of participants in whom, after the maneuvers, no nystagmus is observed in the Dix and Hallpike test
6 months
Secondary Outcomes (3)
Rate of resolution of symptomatology
6 months
DHI score
6 months
Number of sessions
6 months
Study Arms (2)
Conventional Epley maneuver
ACTIVE COMPARATORParticipants will be advised to perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI of the inner ear and posterior cranial fossa will also be requested. If the exercises are ineffective, repositioning maneuvers using a mechanized chair will be repeated biweekly until symptom resolution.
Personalized Epley maneuver
EXPERIMENTALParticipants will perform Brandt-Daroff exercises at home twice daily for 8 weeks. An MRI will be conducted, and based on the images, a personalized mathematical model will be created to modify the angles of the repositioning maneuver. If the exercises are ineffective, the personalized maneuver will be performed using a mechanized chair.
Interventions
Epley maneuver using a mechanized chair
Personalized Epley maneuver, using a mechanized chair
Eligibility Criteria
You may qualify if:
- A. Diagnosed with BPPVp according to the Barany Society criteria:
- Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.
- Episodes lasting less than 1 minute.
- Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right).
- Symptoms not explained by any other cause.
- AND
- B. Refractory to otolith repositioning maneuvers (Epley and/or Semont maneuvers), with persistence of symptoms after three attempts.
You may not qualify if:
- Cognitive impairment that prevents understanding of their condition and the required procedures.
- Pathological conditions that hinder the execution of the maneuvers.
- BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.
- Low educational level, which may impede understanding of the procedures and informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Clinico Universitario de Santiagolead
- Instituto de Salud Carlos IIIcollaborator
- European Unioncollaborator
Study Sites (1)
Hospital Clínico Universitario
Santiago de Compostela, A Coruña, 15706, Spain
Related Publications (1)
Rossi-Izquierdo M, Santos-Perez S, Aran-Tapia I, Blanco-Ulla M, Aran-Gonzalez I, Vaamonde-Sanchez-Andrade I, Franco-Gutierrez V, Perez-Munuzuri V, Munuzuri AP, Soto-Varela A. Personalized medicine to treat refractory benign paroxysmal positional vertigo, through computational fluid dynamics analysis from magnetic resonance image reconstructions. Front Neurol. 2025 Mar 11;16:1561356. doi: 10.3389/fneur.2025.1561356. eCollection 2025.
PMID: 40134694DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrés Soto-Varela, Prof, PhD
Complexo Hospitalario Universitario de Santiago
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chairman
Study Record Dates
First Submitted
December 2, 2024
First Posted
December 10, 2024
Study Start
July 1, 2024
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 10, 2024
Record last verified: 2024-12